Eye

Highly anticipated Sandman Signature Hotel & Suites opens in Dartmouth

Retrieved on: 
Monday, March 11, 2024

DARTMOUTH, Nova Scotia, March 11, 2024 (GLOBE NEWSWIRE) -- Located on Wilkinson Ave, next to Dartmouth Crossing, Sandman Signature Dartmouth Hotel & Suites will immediately catch your eye when driving up Wright Ave.

Key Points: 
  • DARTMOUTH, Nova Scotia, March 11, 2024 (GLOBE NEWSWIRE) -- Located on Wilkinson Ave, next to Dartmouth Crossing, Sandman Signature Dartmouth Hotel & Suites will immediately catch your eye when driving up Wright Ave.
  • “The entire Sandman family is excited for the opening of this fabulous property in Dartmouth.
  • It is our second hotel in Nova Scotia and our first Signature.
  • General Manager, Sinead Doria, and her team invite everyone to take advantage of the hotel’s Opening Celebration Offer by booking online at sandmanhotels.com/signature-dartmouth/hot-deals/opening-celebration-offer to enjoy a premium guest experience at Sandman Signature Dartmouth Hotel & Suites while saving up to 35% off the Standard Rate.

Assertio Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Monday, March 11, 2024

LAKE FOREST, Il., March 11, 2024 (GLOBE NEWSWIRE) --  Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today reported financial results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • Rolvedon net product sales were $11.0 million in the fourth quarter, the first full quarter following the acquisition of Spectrum.
  • Gross margin3 in the fourth quarter was 70%, decreased from 88% in the prior year fourth quarter.
  • Assertio announced its initial 2024 operating guidance as follows:
    For the quarter ended December 31, 2023, cash and cash equivalents totaled $73.4 million.
  • Assertio’s management will host a conference call to discuss its fourth quarter and full year 2023 financial results today:

Rego Payment Architectures, Inc. Launches Accessibility Features for the Visually Impaired

Retrieved on: 
Monday, March 11, 2024

BLUE BELL, Pa., March 11, 2024 (GLOBE NEWSWIRE) -- Rego Payment Architectures, Inc. (“REGO”), the leading white-label family digital wallet platform provider for financial institutions (“REGO”) (OTCQB: RPMT), today announces its release of multiple accessibility features for the visually impaired.

Key Points: 
  • BLUE BELL, Pa., March 11, 2024 (GLOBE NEWSWIRE) -- Rego Payment Architectures, Inc. (“REGO”), the leading white-label family digital wallet platform provider for financial institutions (“REGO”) (OTCQB: RPMT), today announces its release of multiple accessibility features for the visually impaired.
  • Some of the features include the ability for the user to increase the contrast between the foreground text and the background and change the font size of the screen text for improved readability.
  • REGO consulted the guidelines provided by the American Disabilities Act for Web Accessibility when designing these features.
  • “With this latest release, financial institutions who use REGO can be more inclusive in their offering of youth banking products,” said Peter S. Pelullo, CEO at REGO.

Clarkson University Professor Elected to New York State Board of Regents

Retrieved on: 
Friday, March 8, 2024

POTSDAM, NY, March 08, 2024 (GLOBE NEWSWIRE) -- Seema Rivera, an Associate Professor of the Institute for STEM Education at Clarkson University has been elected to the New York State Board of Regents by the State Legislature.

Key Points: 
  • POTSDAM, NY, March 08, 2024 (GLOBE NEWSWIRE) -- Seema Rivera, an Associate Professor of the Institute for STEM Education at Clarkson University has been elected to the New York State Board of Regents by the State Legislature.
  • The Board of Regents is comprised of 17 members elected by the Legislature for five-year terms.
  • Rivera has served on her local school board for the past nine years, a role she will step down from to accept the Board of Regents position.
  • Rivera’s election to the New York State Board of Regents is a well-deserved recognition of the quality of her research and experience in STEM education,” said Clarkson University President Marc P. Christensen, Ph.D., P.E.

Aussie Vapes Granted Import License in Australia  

Retrieved on: 
Friday, March 8, 2024

“As a leading Australian online supplier of aromatherapy products, being granted this TGA import license improves our competitive advantage even further,” said Meni Morim, CEO of Lifeist.

Key Points: 
  • “As a leading Australian online supplier of aromatherapy products, being granted this TGA import license improves our competitive advantage even further,” said Meni Morim, CEO of Lifeist.
  • Aussie Vapes has an important role to play, and we wholeheartedly support the TGA's initiatives to reduce nicotine product misuse by minors.
  • As an established market leader in Australia, Aussie Vapes recognizes that navigating the aromatherapy vaporizer import license application process presents a complicated challenge for smaller participants in the space.
  • As the new market landscape for these devices continues to evolve in Australia, Aussie Vapes will take a leading role in exploring ways to use our import license to help support smaller retailers in a fully regulatorily compliant and transparent fashion.

Obagi Cosmeceuticals Announces the Launch of Daily Hydro-Drops® Rejuvenating Eye Gel Cream

Retrieved on: 
Thursday, March 7, 2024

LONG BEACH, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Obagi Cosmeceuticals LLC (“Obagi”), a leader in skincare innovation and the originator of medical-grade skincare and a subsidiary of Waldencast plc, (NASDAQ: WALD) (“Waldencast”), today announced the launch of Daily Hydro-Drops® Rejuvenating Eye Gel Cream.

Key Points: 
  • LONG BEACH, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Obagi Cosmeceuticals LLC (“Obagi”), a leader in skincare innovation and the originator of medical-grade skincare and a subsidiary of Waldencast plc, (NASDAQ: WALD) (“Waldencast”), today announced the launch of Daily Hydro-Drops® Rejuvenating Eye Gel Cream.
  • Daily Hydro-Drops® Rejuvenating Eye Gel Cream offers a transformative solution to the eye area, bringing an immediate boost in radiance, while simultaneously rejuvenating the eye area with 24-hour lasting hydration for a more awakened appearance.
  • With just one swipe, Rejuvenating Eye Gel Cream delivers brighter, smoother, and more hydrated skin around the eyes.
  • Multimodal efficacy testing was completed to demonstrate the efficacy of Daily Hydro-Drops® Rejuvenating Eye Gel Cream, revealing the below findings after various time increments:
    Daily Hydro-Drops® Rejuvenating Eye Gel Cream is now available for $75 through partnering physician channels, and will be available for customers to purchase on Obagi.com on March 21st.

Alimera Sciences Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Thursday, March 7, 2024

ATLANTA, March 07, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, today announced financial results for the fourth quarter and full year 2023. Alimera will host a conference call today at 9:00 a.m. EDT to discuss these results.

Key Points: 
  • Alimera will host a conference call today at 9:00 a.m. EDT to discuss these results.
  • “We are proud to have achieved positive Adjusted EBITDA during the fourth quarter of 2023, while maintaining a consistent net loss compared to the fourth quarter of 2022, despite facing greater interest and amortization expenses following the YUTIQ acquisition.
  • For 2023, international net revenue increased 21% to approximately $24.0 million for 2023, compared to approximately $19.9 million in 2022.
  • All callers should dial in approximately 10 minutes prior to the scheduled start time and ask to be joined into the Alimera Sciences call.

AGF Appoints Laura Dottori-Attanasio, an Accomplished Leader in the Business Community, to Board of Directors

Retrieved on: 
Thursday, March 7, 2024

Ms. Dottori-Attanasio is a highly accomplished leader in the business community, currently serving as the President and CEO of Element Fleet Management (Element), the largest publicly traded pure-play automotive fleet manager in the world.

Key Points: 
  • Ms. Dottori-Attanasio is a highly accomplished leader in the business community, currently serving as the President and CEO of Element Fleet Management (Element), the largest publicly traded pure-play automotive fleet manager in the world.
  • Before joining Element, Ms. Dottori-Attanasio led the Personal and Business Banking division at one of Canada's largest financial institutions.
  • Dottori-Attanasio further diversifies the collective experience and expertise of our Board as we continue to grow our business,” added Mr. Goldring.
  • "I look forward to working with my fellow directors and to contributing to the company's continued success and growth."

Sosei Heptares to receive US$2.5 million milestone payment from Formosa Pharmaceuticals

Retrieved on: 
Wednesday, March 6, 2024

The milestone has triggered a US$2.5 million payment to Sosei Heptares from Formosa.

Key Points: 
  • The milestone has triggered a US$2.5 million payment to Sosei Heptares from Formosa.
  • APP13007 was originally designed and developed at Activus Pharma Inc. (“Activus”), formerly a wholly owned subsidiary of the Company.
  • Activus was divested in August 2017 to Formosa, a wholly owned subsidiary of Formosa Laboratories, Inc., a leading manufacturer of Active Pharmaceutical Ingredients (“APIs”) listed on the Taiwan Stock Exchange.
  • Under the terms of the sale to Formosa in 2017, Sosei Heptares is entitled to receive undisclosed milestone payments based on progression of Activus’ pipeline as well as royalties from the commercialization of certain products should they reach the market.

Crawford United Corporation Announces Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Tuesday, March 5, 2024

For the quarter ended December 31, 2023, sales were $33.8 million compared with $32.7 million in the same period in 2022, an increase of 3.4%.

Key Points: 
  • For the quarter ended December 31, 2023, sales were $33.8 million compared with $32.7 million in the same period in 2022, an increase of 3.4%.
  • Net income was $3.2 million, or $0.91 per fully diluted share, compared to $3.1 million, or $0.88 per fully diluted share, in the fourth quarter of 2022, an increase of 3.2%.
  • For the year ended December 31, 2023, sales were $143.9 million compared with $127.8 million in 2022, an increase of 12.6%.
  • Crawford United is well positioned to pursue opportunities for increased revenue and profitability, always with an eye towards additional acquisitions.”